Xometry, Inc. (XMTR)
NASDAQIndustrialsIndustrial - DistributionSnapshot 2026-09-04
NASDAQIndustrialsIndustrial - DistributionSnapshot 2026-09-04
Research Workspace
Put XMTR beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Trading Companies & Distributors: fringe margins under pressure (4q confirmed)
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
The reason to own it still holds.
View ThesisRevenue growth is accelerating — up about 34% over the past year.
View GrowthRanks in the weakest quality tier of its industry — roughly the bottom 27%, softest on returns on capital.
View QualityManagement screens weak on capital allocation, margins.
View ManagementExpectations look reasonable — what the market is pricing in sits in line with or below what analysts forecast.
View ValuationThis stock is volatile — it swings about 2% on a typical day and fell roughly 50% in its worst 12-month stretch.
View RiskXMTR's growth trajectory relies on its ability to sustain revenue growth amid market pressures. Revenue grew 41% year over year, and the last quarter beat expectations. It trades at 5.5× price-to-sales versus a peer median of 1.1×. This suggests the price reflects less growth than forecasted. A specific risk is the potential for a credibility hit if XMTR cuts guidance after recently raising it. Peer multiples imply a price about 27% below where it trades. Our read remains intact.
Trailing returns as of 2026-09-04. XMTR is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 11 analysts currently covering XMTR (as of Sep 2026).
Based on 3 Wall Street analysts offering 12-month price targets for XMTR in the last 4 months.
Continue this research
Compare XMTR with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Free account required to save the handoff. No credit card.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| XMTR Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 2 valuation methods, at three horizons. As of 2026-09-04. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Trading Companies & Distributors — fair value, gap to price, and forward P/E.
Compare the value case
Put XMTR next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Stock hitting a high indicates strong market confidence.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-09-04. EPS is implied from price ÷ P/E. Not investment advice.
Current $92.53
The last 12 months of price, then the range of analyst 12-month targets from today’s $92.53.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Advances: Develop strategic partnership with Siemens
Siemens deal aligns with strategic partnership objective.